Literature DB >> 10551753

Upper arm arteriovenous fistulas as a reliable access alternative for patients requiring chronic hemodialysis.

C K Livingston1, J R Potts.   

Abstract

The wrist fistula is the access procedure of choice in the hemodialysis patient. However, unavailable or unusable anatomy in this aging population has made them difficult to establish. This study retrospectively compares patency, occlusion, and complication rates of upper arm arteriovenous fistulas (AVFs) as a reliable alternative. Fifty-eight upper arm AVFs were created in 52 patients between February 1995 and August 1997 at Hermann Hospital, affiliated with the University of Texas Health Science Center in Houston, Texas. Fistulas were constructed using the brachial artery (BA) side-to-end (n = 56) or side-to-side (n = 1) with either the cephalic vein (CV; n = 39), transposed basilic vein (TBV; n = 16), or other vein [basilic vein (BV; n = 1), transposed cephalic vein (TCV; n = 1), median cubital vein (MCV; n = 1)]. One-year primary patency rates for upper arm AVFs were 66 per cent, and secondary patency rates were 22 per cent. Flow rates averaged 354.6 mL/minute. Primary and secondary patency rates for fistulas created are: BA-CV (67% and 20%), BA-TBV (63% and 25%), and other upper arm AVFs 66 per cent without revisions. Primary patencies for both BA-CV and BA-TBV fistulas were similar to previously reported studies. Secondary patencies proved to be less effective. Upper arm AVFs should be considered before graft placement when wrist and forearm anatomy does not lend itself to fistula creation.

Entities:  

Mesh:

Year:  1999        PMID: 10551753

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  1 in total

Review 1.  Vascular access for hemodialysis: current perspectives.

Authors:  Domenico Santoro; Filippo Benedetto; Placido Mondello; Narayana Pipitò; David Barillà; Francesco Spinelli; Carlo Alberto Ricciardi; Valeria Cernaro; Michele Buemi
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.